Effect of continuous ingestion of a beverage prepared with Lactobacillus gasseri CP2305 inactivated by heat treatment on the regulation of intestinal function

Food Research International

Volumn 79, Issue , 2016, Pages 33-39

  Sawada, Daisuke ^a   Sugawara, Tomonori ^a   Ishida, Yu ^a   Aihara, Kohtaro ^a   Aoki, Yumeko ^a   Takehara, Isao ^b   Takano, Kazuhiko ^c   Fujiwara, Shigeru ^a  

^a CALPIS Co Ltd   (Japan)

^b Clinical Support Corporation   (Japan)

^c Medical Corporation Hokubu Kai Utsukushigaoka Hospital   (Japan)

Author keywords

Clostridium cluster IV; Defecation habit; Lactobacillus gasseri CP2305; Paraprobiotics

Indexed keywords

CLOSTRIDIUM; FATTY ACIDS; FERMENTED MILK; LACTIC ACID;

COMMERCIALIZED PRODUCTS; DEFECATION HABIT; GASTROINTESTINAL FUNCTIONS; HEALTHY INDIVIDUALS; LACTIC ACID BACTERIA; LACTOBACILLUS GASSERI; PARAPROBIOTICS; SHORT CHAIN FATTY ACIDS (SCFAS);

BEVERAGES;

EID: 84949844623     PISSN: 09639969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodres.2015.11.032     Document Type: Article

References (27)

1. Adams C.A. The probiotic paradox: Live and dead cells are biological response modifiers. Nutrition Research Reviews 2010, 23(1):37-46. 10.1017/s0954422410000090.
2. Arakawa K., Kawai Y., Nishimura J., Kitazawa H., Saito T. Negative effect of divalent metal cations on production of gassericin T, a bacteriocin produced by Lactobacillus gasseri, in milk-based media. International Dairy Journal 2009, 19(10):612-616. 10.1016/j.idairyj.2009.04.007.
3. Coss-Adame E., Rao S.S. Brain and gut interactions in irritable bowel syndrome: New paradigms and new understandings. Current Gastroenterology Reports 2014, 16(4):379. 10.1007/s11894-014-0379-z.
4. Cryan J.F., Dinan T.G. Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nature Reviews. Neuroscience 2012, 13(10):701-712. 10.1038/nrn3346.
5. Derrien M., van Hylckama Vlieg J.E. Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends in Microbiology 2015, 23(6):354-366. 10.1016/j.tim.2015.03.002.
6. Dinan T.G., Stilling R.M., Stanton C., Cryan J.F. Collective unconscious: How gut microbes shape human behavior. Journal of Psychiatric Research 2015, 63:1-9. 10.1016/j.jpsychires.2015.02.021.
7. Dobson A., Cotter P.D., Ross R.P., Hill C. Bacteriocin production: A probiotic trait?. Applied and Environmental Microbiology 2012, 78(1):1-6. 10.1128/aem.05576-11.
8. FAO/WHO Working Group Guidelines for the evaluation of probiotics in food 2002, Kamje Press, London Ontario, Canada.
9. Foster J.A., McVey Neufeld K.A. Gut-brain axis: How the microbiome influences anxiety and depression. Trends in Neurosciences 2013, 36(5):305-312. 10.1016/j.tins.2013.01.005.
10. Fuller R. Probiotics in man and animals. The Journal of Applied Bacteriology 1989, 66(5):365-378.
11. Ikeda N., Saito Y., Shimizu J., Ochi A., Mizutani J., Watabe J. Variations in concentrations of bacterial metabolites, enzyme activities, moisture, pH and bacterial composition between and within individuals in faeces of seven healthy adults. The Journal of Applied Bacteriology 1994, 77(2):185-194.
12. Kim C.H., Park J., Kim M. Gut microbiota-derived short-chain fatty acids, T cells, and inflammation. Immune Network 2014, 14(6):277-288. 10.4110/in.2014.14.6.277.
13. Lewis S.J., Heaton K.W. Stool form scale as a useful guide to intestinal transit time. Scandinavian Journal of Gastroenterology 1997, 32(9):920-924. 10.3109/00365529709011203.
14. Louis P., Scott K.P., Duncan S.H., Flint H.J. Understanding the effects of diet on bacterial metabolism in the large intestine. Journal of Applied Microbiology 2007, 102(5):1197-1208. 10.1111/j.1365-2672.2007.03322.x.
15. Nagashima K., Hisada T., Sato M., Mochizuki J. Application of new primer-enzyme combinations to terminal restriction fragment length polymorphism profiling of bacterial populations in human feces. Applied and Environmental Microbiology 2003, 69(2):1251-1262.
16. Oggioni M.R., Pozzi G., Valensin P.E., Galieni P., Bigazzi C. Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis. Journal of Clinical Microbiology 1998, 36(1):325-326.
17. Pandey N., Malik R.K., Kaushik J.K., Singroha G. Gassericin A: A circular bacteriocin produced by lactic acid bacteria Lactobacillus gasseri. World Journal of Microbiology and Biotechnology 2013, 29(11):1977-1987. 10.1007/s11274-013-1368-3.
18. Rautio M., Jousimies-Somer H., Kauma H., Pietarinen I., Saxelin M., Tynkkynen S., Koskela M. ). Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clinical Infectious Diseases 1999, 28(5):1159-1160. 10.1086/514766.
19. Rehfeld J.F. Beginnings: A reflection on the history of gastrointestinal endocrinology. Regulatory Peptides 2012, 177:S1-S5. (Supplement). 10.1016/j.regpep.2012.05.087.
20. Salminen S., von Wright A., Morelli L., Marteau P., Brassart D., de Vos W.M., Mattila-Sandholm T. Demonstration of safety of probiotics - A review. International Journal of Food Microbiology 1998, 44(1-2):93-106.
21. Sampson T.R., Mazmanian S.K. Control of brain development, function, and behavior by the microbiome. Cell Host & Microbe 2015, 17(5):565-576. 10.1016/j.chom.2015.04.011.
22. Saulnier D.M., Ringel Y., Heyman M.B., Foster J.A., Bercik P., Shulman R.J., Guarner F. The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes 2013, 4(1):17-27. 10.4161/gmic.22973.
23. Shimizu K., Ogura H., Asahara T., Nomoto K., Morotomi M., Tasaki O., Sugimoto H. Probiotic/synbiotic therapy for treating critically ill patients from a gut microbiota perspective. Digestive Diseases and Sciences 2013, 58(1):23-32. 10.1007/s10620-012-2334-x.
24. Taverniti V., Guglielmetti S. The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: Proposal of paraprobiotic concept). Genes and Nutrition 2011, 6(3):261-274. 10.1007/s12263-011-0218-x.
25. Terada A., Bukawa W., Kan T., Mitsuoka T. Effects of the consumption of heat-killed Enterococcus faecalis EC-12 preparation on microbiota and metabolic activity of the faeces in healthy adults. Microbial Ecology in Health and Disease 2004, 16(4):188-194.
26. Tsukahara T., Tsukahara T., Bukawa W., Kan T., Ushida K. Effect of a cell preparation of Enterococcus faecalis strain EC-12 on digesta flow and recovery from constipation in a pig model and human subjects. Microbial Ecology in Health and Disease 2005, 17(2):107-113.
27. Yano J.M., Yu K., Donaldson G.P., Shastri G.G., Ann P., Ma L., Hsiao E.Y. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 2015, 161(2):264-276. 10.1016/j.cell.2015.02.047.